POMDOCTOR Ltd (POM) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
POM Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
Compared to the Healthcare sector median P/E of 22.3x, POM trades at a 113% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, POM trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our POM DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
POM P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $7B | 50.3 | - | -4% | |
| $5B | 23.5Lowest | 0.30Best | +54% | |
| $149B | 153.3 | - | -11% | |
| $973M | 33.3 | - | +104%Best | |
| $868M | 129.5 | - | - | |
| $27B | 30.9 | 1.70 | +26% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See POM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs POM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare POM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPOM — Frequently Asked Questions
Quick answers to the most common questions about buying POM stock.
Is POM stock overvalued or undervalued?
POM current P/E: -3.0x. 5-year average P/E: N/A. Percentile: N/A.
How does POM's valuation compare to peers?
POMDOCTOR Ltd P/E of -3.0x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is POM's PEG ratio?
POM PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.